Doxycycline inhibition of interleukin-1 in the corneal epithelium

A. Solomon, M. Rosenblatt, D. Q. Li, Z. Liu, D. Monroy, Z. Ji, B. L. Lokeshwar, S. C. Pflugfelder

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

PURPOSE. To evaluate the effect of doxycycline on the regulation of interleukin (IL)-1 expression and activity in human cultured corneal epithelium. METHODS. Human corneal limbal epithelium (HLE) was cultured from explants prepared from limbal rings of donor corneas. Primary cultured limbal epithelial cells were treated with either 10 μg/ml lipopolysaccharide (LPS), LPS with 10 μg/ml doxycycline, or LPS with 0.1 mg/ml methylprednisolone (MP) for 24 hours. The intracellular and supernatant protein amounts of IL-1α, the precursor and mature forms of IL-1β, IL-1 receptor antagonist (IL-1 RA), and the intracellular level of IL-1β-converting enzyme (ICE) were measured with enzyme-linked immunosorbent assays (ELISAs). Western blot analysis was performed to evaluate IL-1 RA protein. mRNA steady state amounts were determined by RNase protection assay (RPA) for IL-1α, IL-1β, IL-1 RA, and ICE. RESULTS. LPS increased the mRNA and protein amounts of intracellular and released IL-1α, mature IL-1β, and IL-1 RA. Doxycycline inhibited the LPS-induced IL-1β increased in the mRNA and protein amounts in the corneal epithelium and upregulated the expression of the anti-inflammatory IL-1 RA protein. In addition, doxycycline reduced the steady state level of the cellular ICE protein but did not affect the level of ICE transcripts. IL-1β secreted to the conditioned media of HLE was functionally active in inducing matrix metalloproteinase (MMP)-1 and MMP-3 in cultured corneal fibroblasts. Doxycycline significantly decreased IL-1β bioactivity in the supernatants from LPS-treated corneal epithelial cultures. These effects were comparable to those induced by the corticosteroid, MP. CONCLUSIONS. Doxycycline can suppress the steady state amounts of mRNA and protein of IL-β and decrease the bioactivity of this major inflammatory cytokine. These data may partially explain the clinically observed anti-inflammatory properties of doxycycline. The observation that doxycycline was equally potent as a corticosteroid, combined with the relative absence of adverse effects, makes it a potent drug for a wide spectrum of ocular surface inflammatory diseases.

Original languageEnglish
Pages (from-to)2544-2557
Number of pages14
JournalInvestigative Ophthalmology and Visual Science
Volume41
Issue number9
StatePublished - Aug 29 2000
Externally publishedYes

Fingerprint

Corneal Epithelium
Doxycycline
Interleukin-1
Lipopolysaccharides
Proteins
Messenger RNA
Methylprednisolone
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Enzymes
Caspase 1
Matrix Metalloproteinase 3
Matrix Metalloproteinase 1
Interleukin-1 Receptors
Interleukins
Ribonucleases
Conditioned Culture Medium

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Solomon, A., Rosenblatt, M., Li, D. Q., Liu, Z., Monroy, D., Ji, Z., ... Pflugfelder, S. C. (2000). Doxycycline inhibition of interleukin-1 in the corneal epithelium. Investigative Ophthalmology and Visual Science, 41(9), 2544-2557.

Doxycycline inhibition of interleukin-1 in the corneal epithelium. / Solomon, A.; Rosenblatt, M.; Li, D. Q.; Liu, Z.; Monroy, D.; Ji, Z.; Lokeshwar, B. L.; Pflugfelder, S. C.

In: Investigative Ophthalmology and Visual Science, Vol. 41, No. 9, 29.08.2000, p. 2544-2557.

Research output: Contribution to journalArticle

Solomon, A, Rosenblatt, M, Li, DQ, Liu, Z, Monroy, D, Ji, Z, Lokeshwar, BL & Pflugfelder, SC 2000, 'Doxycycline inhibition of interleukin-1 in the corneal epithelium', Investigative Ophthalmology and Visual Science, vol. 41, no. 9, pp. 2544-2557.
Solomon A, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Investigative Ophthalmology and Visual Science. 2000 Aug 29;41(9):2544-2557.
Solomon, A. ; Rosenblatt, M. ; Li, D. Q. ; Liu, Z. ; Monroy, D. ; Ji, Z. ; Lokeshwar, B. L. ; Pflugfelder, S. C. / Doxycycline inhibition of interleukin-1 in the corneal epithelium. In: Investigative Ophthalmology and Visual Science. 2000 ; Vol. 41, No. 9. pp. 2544-2557.
@article{f355c6b726f94b9ba639aafa7c82a741,
title = "Doxycycline inhibition of interleukin-1 in the corneal epithelium",
abstract = "PURPOSE. To evaluate the effect of doxycycline on the regulation of interleukin (IL)-1 expression and activity in human cultured corneal epithelium. METHODS. Human corneal limbal epithelium (HLE) was cultured from explants prepared from limbal rings of donor corneas. Primary cultured limbal epithelial cells were treated with either 10 μg/ml lipopolysaccharide (LPS), LPS with 10 μg/ml doxycycline, or LPS with 0.1 mg/ml methylprednisolone (MP) for 24 hours. The intracellular and supernatant protein amounts of IL-1α, the precursor and mature forms of IL-1β, IL-1 receptor antagonist (IL-1 RA), and the intracellular level of IL-1β-converting enzyme (ICE) were measured with enzyme-linked immunosorbent assays (ELISAs). Western blot analysis was performed to evaluate IL-1 RA protein. mRNA steady state amounts were determined by RNase protection assay (RPA) for IL-1α, IL-1β, IL-1 RA, and ICE. RESULTS. LPS increased the mRNA and protein amounts of intracellular and released IL-1α, mature IL-1β, and IL-1 RA. Doxycycline inhibited the LPS-induced IL-1β increased in the mRNA and protein amounts in the corneal epithelium and upregulated the expression of the anti-inflammatory IL-1 RA protein. In addition, doxycycline reduced the steady state level of the cellular ICE protein but did not affect the level of ICE transcripts. IL-1β secreted to the conditioned media of HLE was functionally active in inducing matrix metalloproteinase (MMP)-1 and MMP-3 in cultured corneal fibroblasts. Doxycycline significantly decreased IL-1β bioactivity in the supernatants from LPS-treated corneal epithelial cultures. These effects were comparable to those induced by the corticosteroid, MP. CONCLUSIONS. Doxycycline can suppress the steady state amounts of mRNA and protein of IL-β and decrease the bioactivity of this major inflammatory cytokine. These data may partially explain the clinically observed anti-inflammatory properties of doxycycline. The observation that doxycycline was equally potent as a corticosteroid, combined with the relative absence of adverse effects, makes it a potent drug for a wide spectrum of ocular surface inflammatory diseases.",
author = "A. Solomon and M. Rosenblatt and Li, {D. Q.} and Z. Liu and D. Monroy and Z. Ji and Lokeshwar, {B. L.} and Pflugfelder, {S. C.}",
year = "2000",
month = "8",
day = "29",
language = "English",
volume = "41",
pages = "2544--2557",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "9",

}

TY - JOUR

T1 - Doxycycline inhibition of interleukin-1 in the corneal epithelium

AU - Solomon, A.

AU - Rosenblatt, M.

AU - Li, D. Q.

AU - Liu, Z.

AU - Monroy, D.

AU - Ji, Z.

AU - Lokeshwar, B. L.

AU - Pflugfelder, S. C.

PY - 2000/8/29

Y1 - 2000/8/29

N2 - PURPOSE. To evaluate the effect of doxycycline on the regulation of interleukin (IL)-1 expression and activity in human cultured corneal epithelium. METHODS. Human corneal limbal epithelium (HLE) was cultured from explants prepared from limbal rings of donor corneas. Primary cultured limbal epithelial cells were treated with either 10 μg/ml lipopolysaccharide (LPS), LPS with 10 μg/ml doxycycline, or LPS with 0.1 mg/ml methylprednisolone (MP) for 24 hours. The intracellular and supernatant protein amounts of IL-1α, the precursor and mature forms of IL-1β, IL-1 receptor antagonist (IL-1 RA), and the intracellular level of IL-1β-converting enzyme (ICE) were measured with enzyme-linked immunosorbent assays (ELISAs). Western blot analysis was performed to evaluate IL-1 RA protein. mRNA steady state amounts were determined by RNase protection assay (RPA) for IL-1α, IL-1β, IL-1 RA, and ICE. RESULTS. LPS increased the mRNA and protein amounts of intracellular and released IL-1α, mature IL-1β, and IL-1 RA. Doxycycline inhibited the LPS-induced IL-1β increased in the mRNA and protein amounts in the corneal epithelium and upregulated the expression of the anti-inflammatory IL-1 RA protein. In addition, doxycycline reduced the steady state level of the cellular ICE protein but did not affect the level of ICE transcripts. IL-1β secreted to the conditioned media of HLE was functionally active in inducing matrix metalloproteinase (MMP)-1 and MMP-3 in cultured corneal fibroblasts. Doxycycline significantly decreased IL-1β bioactivity in the supernatants from LPS-treated corneal epithelial cultures. These effects were comparable to those induced by the corticosteroid, MP. CONCLUSIONS. Doxycycline can suppress the steady state amounts of mRNA and protein of IL-β and decrease the bioactivity of this major inflammatory cytokine. These data may partially explain the clinically observed anti-inflammatory properties of doxycycline. The observation that doxycycline was equally potent as a corticosteroid, combined with the relative absence of adverse effects, makes it a potent drug for a wide spectrum of ocular surface inflammatory diseases.

AB - PURPOSE. To evaluate the effect of doxycycline on the regulation of interleukin (IL)-1 expression and activity in human cultured corneal epithelium. METHODS. Human corneal limbal epithelium (HLE) was cultured from explants prepared from limbal rings of donor corneas. Primary cultured limbal epithelial cells were treated with either 10 μg/ml lipopolysaccharide (LPS), LPS with 10 μg/ml doxycycline, or LPS with 0.1 mg/ml methylprednisolone (MP) for 24 hours. The intracellular and supernatant protein amounts of IL-1α, the precursor and mature forms of IL-1β, IL-1 receptor antagonist (IL-1 RA), and the intracellular level of IL-1β-converting enzyme (ICE) were measured with enzyme-linked immunosorbent assays (ELISAs). Western blot analysis was performed to evaluate IL-1 RA protein. mRNA steady state amounts were determined by RNase protection assay (RPA) for IL-1α, IL-1β, IL-1 RA, and ICE. RESULTS. LPS increased the mRNA and protein amounts of intracellular and released IL-1α, mature IL-1β, and IL-1 RA. Doxycycline inhibited the LPS-induced IL-1β increased in the mRNA and protein amounts in the corneal epithelium and upregulated the expression of the anti-inflammatory IL-1 RA protein. In addition, doxycycline reduced the steady state level of the cellular ICE protein but did not affect the level of ICE transcripts. IL-1β secreted to the conditioned media of HLE was functionally active in inducing matrix metalloproteinase (MMP)-1 and MMP-3 in cultured corneal fibroblasts. Doxycycline significantly decreased IL-1β bioactivity in the supernatants from LPS-treated corneal epithelial cultures. These effects were comparable to those induced by the corticosteroid, MP. CONCLUSIONS. Doxycycline can suppress the steady state amounts of mRNA and protein of IL-β and decrease the bioactivity of this major inflammatory cytokine. These data may partially explain the clinically observed anti-inflammatory properties of doxycycline. The observation that doxycycline was equally potent as a corticosteroid, combined with the relative absence of adverse effects, makes it a potent drug for a wide spectrum of ocular surface inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=0033854287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033854287&partnerID=8YFLogxK

M3 - Article

C2 - 10937565

AN - SCOPUS:0033854287

VL - 41

SP - 2544

EP - 2557

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 9

ER -